{"id":901068,"date":"2025-10-28T09:27:08","date_gmt":"2025-10-28T13:27:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-releases-new-survey-findings-revealing-heightened-concerns-about-biological-threats-and-u-s-preparedness\/"},"modified":"2025-10-28T09:27:08","modified_gmt":"2025-10-28T13:27:08","slug":"emergent-biosolutions-releases-new-survey-findings-revealing-heightened-concerns-about-biological-threats-and-u-s-preparedness","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-releases-new-survey-findings-revealing-heightened-concerns-about-biological-threats-and-u-s-preparedness\/","title":{"rendered":"Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness"},"content":{"rendered":"

\nPolicy opinion leaders believe a biological attack is both more likely and easier to execute than a nuclear strike, highlighting concerns around bioterrorism and the nation\u2019s readiness to respond
\n<\/h2>\n
\n

GAITHERSBURG, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of a new survey1<\/sup> of approximately 250 U.S. policy opinion leaders showing that nearly two-thirds (65 percent) of respondents agree the likelihood of a biological attack on U.S. soil is rising, yet almost half (45 percent) believe the U.S. is unprepared for a biological attack. Conducted by Penta Group on behalf of Emergent, the survey amplifies findings in the unclassified 2025 Annual Threat Assessment of the U.S. Intelligence Community which highlights continued, serious concerns that adversarial nations possess biological and chemical weapons and that additional countries are continuing their research and development of chemical, biological, and pharmaceutical-based agents.2<\/sup><\/p>\n

\u201cThe risk of bio attacks in the U.S. and around the world is significant, and perhaps even more dangerous than nuclear weapons, given the relative low cost and overall ease to produce, especially today with the enabler of artificial intelligence,\u201d said Hon. Andy Weber, Senior Fellow at the Council on Strategic Risk and former Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. \u201cTo meet today\u2019s threat we need robust surveillance, stockpiles of PPE and medical countermeasures, and established partnerships to rapidly develop, produce, and deliver vaccines and medicines to address bioengineered or novel threats.\u201d<\/p>\n

Despite the establishment of international treaties such as the Chemical Weapons Convention (CWC) and the Biological and Toxin Weapons Convention (BTWC), emerging threats posed by non-traditional agents, particularly central nervous system (CNS)-acting chemicals and biotoxins, present ongoing challenges to international security.3<\/sup> Foreign adversary research on pharmaceutical based agents is known to include the development and autonomous deployment of highly potent, weaponized synthetic opioids, like aerosolized fentanyl and medetomidine.4<\/sup> Aerosolized fentanyl caused the death of 130 civilians during the Dubrovka Theater attack in Moscow 2002.<\/p>\n

Additionally, from the new survey, policy opinion leaders also see biological threats as a top national security concern, outpacing concerns over nuclear threats. Of note:<\/p>\n